Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Rossi

Showing results (11-20 of 503) with videos related to

Pageof 51
Sort By:
The Lancet. Oncology|May 15, 2016
Venetoclax: a new weapon to treat high-risk CLLDavide Rossi
Leukemia Research|January 9, 2009
Thyroid lymphoma: beyond antigen stimulationDavide Rossi
Leukemia & Lymphoma|January 24, 2013
MYC addiction in chronic lymphocytic leukemiaDavide Rossi
Leukemia & Lymphoma|October 8, 2013
Notch signaling in peripheral T-cell lymphoma: revelations from immunohistochemistryDavide Rossi
Blood Cancer Discovery|October 18, 2021
Epigenetic Trajectories of the Premalignant-to-Malignant Transition of Chronic Lymphocytic LeukemiaDavide Rossi
Current Treatment Options in Oncology|November 22, 2017
Treatment of Richter's SyndromeAdalgisa Condoluci, Davide Rossi
Expert Review of Hematology|January 29, 2019
Genetic mutations in chronic lymphocytic leukemia: impact on clinical treatmentAdalgisa Condoluci, Davide Rossi
Seminars in Oncology|April 5, 2016
Richter syndrome: pathogenesis and managementDavide Rossi, Gianluca Gaidano
Clinical Lymphoma, Myeloma & Leukemia|October 11, 2020
SOHO State of the Art Updates and Next Questions: Clonal Evolution in Chronic Lymphocytic LeukemiaAdalgisa Condoluci, Davide Rossi
Blood|March 22, 2014
Lymphocytosis and ibrutinib treatment of CLLDavide Rossi, Gianluca Gaidano
Pageof 51

Showing results (11-20 of 503) with videos related to

Sort By:
Pageof 51
The Lancet. Oncology|May 15, 2016
Venetoclax: a new weapon to treat high-risk CLLDavide Rossi
Leukemia Research|January 9, 2009
Thyroid lymphoma: beyond antigen stimulationDavide Rossi
Leukemia & Lymphoma|January 24, 2013
MYC addiction in chronic lymphocytic leukemiaDavide Rossi
Leukemia & Lymphoma|October 8, 2013
Notch signaling in peripheral T-cell lymphoma: revelations from immunohistochemistryDavide Rossi
Blood Cancer Discovery|October 18, 2021
Epigenetic Trajectories of the Premalignant-to-Malignant Transition of Chronic Lymphocytic LeukemiaDavide Rossi
Current Treatment Options in Oncology|November 22, 2017
Treatment of Richter's SyndromeAdalgisa Condoluci, Davide Rossi
Expert Review of Hematology|January 29, 2019
Genetic mutations in chronic lymphocytic leukemia: impact on clinical treatmentAdalgisa Condoluci, Davide Rossi
Seminars in Oncology|April 5, 2016
Richter syndrome: pathogenesis and managementDavide Rossi, Gianluca Gaidano
Clinical Lymphoma, Myeloma & Leukemia|October 11, 2020
SOHO State of the Art Updates and Next Questions: Clonal Evolution in Chronic Lymphocytic LeukemiaAdalgisa Condoluci, Davide Rossi
Blood|March 22, 2014
Lymphocytosis and ibrutinib treatment of CLLDavide Rossi, Gianluca Gaidano
Pageof 51